We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$214M
AUM Growth
+$4.1M
Cap. Flow
-$758K
Cap. Flow %
-0.35%
Top 10 Hldgs %
10.99%
Holding
242
New
22
Increased
21
Reduced
29
Closed
23

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$2.67M
2
XOM icon
ExxonMobil
XOM
+$1.63M
3
CRM icon
Salesforce
CRM
+$1.48M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.45M
5
AMZN icon
Amazon
AMZN
+$1.42M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 14.4%
3 Healthcare 14.07%
4 Industrials 12.13%
5 Consumer Discretionary 11.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAST icon
226
Fastenal
FAST
$54.5B
-83,660
Closed -$1.02M
GRMN
227
Garmin
GRMN
$46.7B
-11,609
Closed -$464K
HP icon
228
Helmerich & Payne
HP
$3.39B
-24,691
Closed -$1.45M
INTU icon
229
Intuit
INTU
$84.4B
-5,646
Closed -$587K
JNPR
230
DELISTED
Juniper Networks
JNPR
-41,267
Closed -$1.05M
MLM icon
231
Martin Marietta Materials
MLM
$34.3B
-4,812
Closed -$768K
RL icon
232
Ralph Lauren
RL
$22.5B
-3,648
Closed -$351K
RMD icon
233
ResMed
RMD
$29.3B
-22,484
Closed -$1.3M
SBAC icon
234
SBA Communications
SBAC
$18.3B
-7,407
Closed -$742K
SCHW
235
Charles Schwab
SCHW
$180B
-55,564
Closed -$1.56M
VTRS icon
236
Viatris
VTRS
$20.4B
-11,043
Closed -$512K
LUMO
237
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
-1,603
Closed -$263K
BBBY
238
DELISTED
Bed Bath & Beyond Inc
BBBY
-14,105
Closed -$700K
ALXN
239
DELISTED
Alexion Pharmaceuticals
ALXN
-5,195
Closed -$723K
VIAB
240
DELISTED
Viacom Inc. Class B
VIAB
-25,568
Closed -$1.05M
TFCFA
241
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
-36,817
Closed -$1.03M
LLTC
242
DELISTED
Linear Technology Corp
LLTC
-24,262
Closed -$1.08M

Similar funds

Capital Impact Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Capital Impact Advisors held 242 positions worth $214M, up 2% from $210M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Capital Impact Advisors's Q2 2016 filing shows 22 new, 21 increased, 29 reduced and 23 closed positions. Its largest new stake was ExxonMobil: 18,463 shares worth $1.73M. The largest sale was Jazz Pharmaceuticals, an estimated $1.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Capital Impact Advisors's largest Q2 2016 buy was ExxonMobil: 18,463 shares worth $1.73M.
  • Capital Impact Advisors added most to United Therapeutics in Q2 2016, an estimated $2.67M increase.
  • Capital Impact Advisors's biggest Q2 2016 reduction was Jazz Pharmaceuticals, cutting an estimated $1.78M.
  • Capital Impact Advisors fully exited Charles Schwab in Q2 2016, selling an estimated $1.56M.
  • Capital Impact Advisors's ten largest holdings make up 11% of its $214M portfolio in Q2 2016.
  • Capital Impact Advisors opened 22 new positions and closed 23 in Q2 2016.
  • Capital Impact Advisors's portfolio value rose 2% quarter-over-quarter to $214M.

Based on Capital Impact Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.